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Abstract
Objective
To evaluate the validity of WHO’s near-miss approach in a low-resource, high maternal mor-
tality setting.
Design
Prospective cohort study.
Setting
Mnazi Mmoja Hospital, the main referral hospital of Zanzibar, Tanzania, from 1 April 2017
until 31 December 2018.
Population
All women, pregnant or until 42 days after the end of pregnancy, admitted at Mnazi Mmoja
Hospital, the tertiary referral hospital in Zanzibar.
Methods
Cases of maternal morbidity and mortality were evaluated according to WHO’s near-miss
approach. The approach’s performance was determined by calculating its accuracy through
sensitivity, specificity and positive and negative likelihood ratios. The approach’s validity
was assessed with Pearson’s correlation coefficient between the number of organ dysfunc-
tion markers and risk of mortality.
Main outcomes measures
Correlation between number of organ dysfunction markers and risk of mortality, sensitivity
and specificity.
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Results
26,842 women were included. There were 335 with a severe maternal outcome: 256 mater-
nal near-miss cases and 79 maternal deaths. No signs of organ dysfunction were docu-
mented in only 4 of the 79 cases of maternal death. The number of organ dysfunction
markers was highly correlated to the risk of mortality with Pearson’s correlation coefficient of
0.89.
Conclusions
WHO’s near-miss approach adequately identifies women at high risk of maternal mortality in
Zanzibar’s referral hospital. There is a strong correlation between the number of markers of
organ dysfunction and mortality risk.
Introduction
With globally declining maternal mortality rates (MMR), assessment of severe maternal mor-
bidity is increasingly important in addition to maternal death reviews to evaluate the quality of
maternal health care. This has led to reviews and audits of maternal morbidity in not only mid-
dle- and high-income countries, where mortality rates are low, but also at facility-level in low-
income settings where, despite high morbidity and mortality rates, maternal deaths are rela-
tively rare events. Severe maternal morbidity cases should, however, be selected in such a way
as to reflect the same processes as maternal mortality cases. That assumption is not straightfor-
ward because causes of severe maternal morbidity are not necessarily those leading to maternal
death [1]. In order to draw valid conclusions from an audit process combining maternal mor-
bidity and mortality, one should therefore select cases in which the woman nearly died, desig-
nated by the term maternal “near-misses” [2]. The definition of near-misses however intuitive
is not unequivocal in practice [3–5]. This led the World Health Organization (WHO) to pro-
pose a definition using markers of organ failure, based on scoring systems used in intensive
care medicine: the WHO near-miss approach [4]. In practice, this approach uses a two-step
system in which women potentially at risk of dying are identified first through disease- and
management-based criteria. This is followed by identification of women within this group that
are really at risk of dying based on the occurrence of markers of organ failure [2,4]. The final
clinical outcome for women in these group is either near-miss—those who survived—or
death.
The validity of this approach has been tested in a Brazilian setting with a maternal mortality
rate of 170 deaths per 100,000 live births; the number of markers of organ failure appeared to
correlate well with the risk of death [6]. Its applicability to settings with higher mortality rates
has been established in a large multinational study [7] and several single facility studies [8–10].
However, its validity has never been confirmed in high mortality settings where limited access
to diagnostic tools could hamper its validity.
The objective of the current study is to evaluate the validity of WHO’s near-miss approach
in a high mortality, low-resource setting by assessing the correlation between the mortality
risk and the number of organ dysfunction markers as well as evaluating the number of mater-
nal mortality cases missed by this approach. Secondly, we will compare the type of organ dys-
functions observed in morbidity and mortality cases to test the underlying assumption of a
common pathway.
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Methods
Setting
Zanzibar is an East African archipelago, semi-autonomous to Tanzania and Mnazi Mmoja
Hospital (MMH) is its referral hospital. The Obstetrics & Gynaecology (O&G) department of
MMH accommodates 11,000 to 13,000 deliveries per year and on average one maternal death
occurs per week. Health care services such as essential obstetrical interventions and an inten-
sive care unit (ICU) are generally available and accessible, although not consistently of good
quality. The in-hospital maternal mortality ratio (IH-MMR) is above 400 per 100,000 live
births [11].
Study design
Data collection for this study was performed under two research projects (reference numbers
ZAMREC/0001/AUGUST/005 and ZAMREC/001/JAN/17) approved by Zanzibar’s Medical
Ethical Research Committee. Informed consent was waived because the study concerned only
an analysis of clinical files with aggregated, anonymous outcomes.
All cases of maternal near miss and maternal mortality were prospectively identified
amongst all women, pregnant or within 42 days after end of pregnancy, admitted to MMH
between 1 April 2017 and 31 December 2018. Department-level data on the number of deliver-
ies and live births were extracted from the hospital’s records. MNM cases were identified dur-
ing the O&G department’s daily clinical staff meetings in which all severe cases were
discussed. Simultaneously with this study, a maternal near-miss audit study was performed,
contributing to improved case identification and awareness of maternal morbidity within the
department. When a patient fulfilled a near-miss criterion, she was actively followed-up by
one of the research assistants and the clinical staff. Throughout the entire study period, mater-
nal death cases were identified soon after their occurrence. Maternal death reviews were con-
ducted within 72 hours of the event by the local maternal death review committee consisting
of medical doctors of the O&G department, nurse-midwives, an anaesthetist, health workers
from the laboratory and blood bank and doctors and nurses from the ICU. Medical files of
maternal near-misses and death, when retrieved, were saved, separate from the other files. Rel-
evant information from the patient file, including socio-demographic characteristic, basic
obstetric history, a summary of admission, and perinatal and maternal outcomes, was coded,
anonymized, stored in a Microsoft Excel spreadsheet and backed-up, accessible to the study
team members with a password.
Classification of MNM and mortality cases followed WHO’s near-miss approach. A patient
in life-threatening condition was identified following the approach’s set of clinical, laboratory
or management-based markers for organ dysfunction, adapted to local availability, as indi-
cated in Table 1. The maternal outcome for these patients was either near-miss or death. The
present markers were added to the individual case data in the beforementioned spreadsheet.
Guided by previous research experience in MMH’s O&G department, we anticipated issues
of missing data and poor quality of data. Measures were taken to minimize the influence
hereof, such as close collaboration of the researchers and research assistants with the depart-
ment’s nurses, daily physical presence of the data collectors and weekly updates of data storage.
Next to this, ongoing initiatives in the O&G department, in addition to the daily clinical staff
meetings, also aimed at improvement of qualitative documentation in patient files. Amongst
these projects were the full-time dedication of a registrar to department-level data and the
beforementioned maternal near-miss audits. Nevertheless, poor documentation remained an
issue.
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Data collection was performed by junior investigators (TH, LA, RSK) and seven research
assistants throughout the study period, none of whom were involved in patient care. Each
research assistant worked on the study for a period of at least 12 weeks and was trained by
their predecessor. Training and data collection were supervised by TH and TM. Data quality
checks were performed weekly by TH in the spreadsheet and through discussion with the
research assistants face to face or, in case of absence from the study site, over telephone. BJ per-
formed additional checks on consistency and quality of the data.
Data analysis
Incidences and ratios of maternal outcomes were assessed with descriptive statistics. These
outcome measures are defined in S1 Table. The distribution of dysfunction of the different
Table 1. Markers for organ dysfunction, identifying cases in life-threatening condition.
Type of organ
dysfunction
Markers (clinical signs, laboratory markers and management actions)
Cardiovascular Shock1, use of continuous vasoactive drugs, cardiac arrest, cardio-pulmonary
resuscitation, severe hypoperfusion (lactate >5 mmol/L or >45mg/dL)2 or severe
acidosis (pH <7.1)2
Respiratory Acute cyanosis, gasping3, severe tachypnea (respiratory rate >40bpm), severe
bradypnea (respiratory rate <6bpm), severe hypoxemia (PAO2/FiO2 <200mmHg2 or
O2 saturation <90% for�60min) or intubation and ventilation not related to
anaesthesia
Renal Oliguria4 non-responsive to fluids or diuretics, dialysis for acute renal failure5 or severe
acute azotaemia (creatinine�300umol/ml or�3.5mg/dL)
Coagulation /
haematological
Clotting failure6, use of continuous vasoactive drugs7, massive transfusion of blood or
red cells (�5 units)8 or severe acute thrombocytopenia (<50,000 platelets/ml)
Hepatic Jaundice in the presence of pre-eclampsia9, severe acute hyperbilirubinemia (bilirubin
>100umol/L or >6.0mg/dL)
Neurological Prolonged unconsciousness (lasting >12 hours)/coma10, stroke11, status epilepticus12,
uncontrollable fits/total paralysis
Uterine Hysterectomy following haemorrhage or infection
Unless otherwise stated, the criteria are reproduced from Say et al. [4]
1) Shock is a persistent severe hypotension, defined as a systolic blood pressure<90 mmHg for�60 minutes with a
pulse rate at least 120 despite aggressive fluid replacement (>2l)
2) Laboratory test or management intervention that is not available at MMH
3) Gasping is a terminal respiratory pattern and the breath is convulsively and audibly caught
4) Oliguria is defined as a urinary output <30 ml/hr for 4 hours or <400 ml/24 hr
5) Dialysis services have been available in MMH since 26 May 2017
6) Clotting failure can be assessed by the bedside clotting test or absence of clotting from the intravenous site after
7–10 minutes
7) For instance, continuous use of any dose of dopamine, epinephrine or norepinephrine
8) In MMH extended to include all types of blood products and cases in which 5 or more units were requested but
not given due to shortage
9) Pre-eclampsia is defined as the presence of hypertension associated with proteinuria. Hypertension is defined as a
blood pressure of at least 140 mmHg (systolic) or at least 90 mmHg (diastolic) on at least two occasions and at least
4–6 h apart after the 20th week of gestation in women known to be normotensive beforehand. In MMH, proteinuria
is defined as �2+ protein on dipstick.
10) Loss of consciousness is a profound alteration of mental state that involves complete or near-complete lack of
responsiveness to external stimuli. It is defined as a Coma Glasgow Scale <10 (moderate or severe coma).
11) Stroke is a neurological deficit of cerebrovascular cause that persists beyond 24 hours or is interrupted by death
within 24 hours
Condition in which the brain is in a state of continuous seizure
https://doi.org/10.1371/journal.pone.0217135.t001
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organ systems was assessed with descriptive statistics in the group of women with severe
maternal outcomes (SMO), including both MNM and MD, and separately for the MNM and
MD groups. Relative risk ratios (RR) with a 95% confidence interval were calculated to com-
pare the incidence of a specific type of organ dysfunction in MNM and MD cases.
To analyse the performance of the set of WHO near-miss criteria in this setting, its sensitiv-
ity, specificity, positive likelihood ratio and negative likelihood ratio were calculated, given an
estimation of its accuracy. Performance in this is defined as the set of criteria’s ability to detect
those patients with life-threatening, organ function-violating morbidity. The calculations were
performed in the group of only the patients with severe complications.
To analyse the validity of the WHO near-miss approach in the study setting, the number of
organ dysfunction markers has been plotted against the mortality risk and their relation has
been evaluated using Pearson’s correlation coefficient.
Results
During the 21-months study period, 26,842 women admitted at MMH–pregnant or within 42
days after end of pregnancy–were included. There were 22,054 deliveries and 22,011 recorded
live births (including all live births in cases of multiple pregnancies), 335 (1.3%) women had a
severe maternal outcome (SMO), with 256 (1.0%) maternal near-misses and 79 (0.3%) mater-
nal deaths. Maternal outcomes are further detailed in Table 2. The in-hospital maternal mor-
tality ratio (MMR) was 359 per 100,000 live births. A high mortality index (MI) of 0.24 was
found, indicating that of all women undergoing very severe morbidity, close to one quarter
had died.
The distribution of organ dysfunction criteria found in women experiencing a life-threaten-
ing condition is shown in Table 3. Cardiovascular and coagulation organ dysfunction were
most prevalent in all women with SMO, 46% and 52%, respectively. Signs of organ dysfunction
of the cardiovascular, respiratory, neurological, hepatic and renal systems were significantly
more likely to be found in MD than in MNM cases. The highest relative risk ratios were found
for respiratory and cardiovascular organ dysfunction, with 5.21 (95% CI 3.34–8.14) and 5.08
(95% CI 3.02–8.53), respectively. By contrast, coagulation disorders and uterine dysfunction
were less prevalent in MD cases compared to MNM, with risk ratios of 0.34 (95% CI 0.22–
0.53) and 0.58 (95% CI 0.35–0.97), respectively.
Markers of organ dysfunction were not documented in only 4 out of 79 maternal deaths
(5.0%). Adding other criteria such as eclampsia, uterine rupture or sepsis and/or modifying
transfusion thresholds further than already performed as suggested by others [12–15] does
Table 2. Overview of maternal outcomes.
Maternal outcomes N (% of total1)
Severe maternal outcome cases 335 (1.3)
Maternal near-miss cases 256 (1.0)
Maternal death cases 79 (0.3)
Overall severe morbidity, near-miss and mortality indicators
Severe maternal outcome ratio (per 1000 live births) 15.2
Maternal near-miss incidence ratio (per 1000 live births) 11.6
Maternal near-miss mortality ratio 3.2
In-hospital maternal mortality ratio (per 100,000 live births) 359
Mortality index (MD/SMO) 0.24
1) total = 26,842 included women
https://doi.org/10.1371/journal.pone.0217135.t002
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not, therefore, improve the predictive accuracy of the model. Overall, as outlined in Table 4,
the near-miss criteria’s accuracy in identifying women with life-threatening conditions was
found to be high.
Fig 1 shows the relation between the number of markers of organ dysfunction and the risk
of mortality. A number of signs of organ dysfunction of six or more (25 of 335) was associated
with a 100% risk of mortality. We found a correlation coefficient between the number of sever-
ity markers and the risk of death of 0.89, similar to the coefficient of 0.96 found in the seminal
study in Brazil [6]. The relation between mortality risk and number of severity markers seems
roughly linear in both settings. The main difference lies in the slope of the curve, which is
steeper in this study. Women in Zanzibar’s referral hospital have an increased mortality risk
even with a low number of severity markers: 5% of women with one marker of organ dysfunc-
tion will die. This risk further increases with increasing number of severity markers.
Discussion
Main findings
This study shows a strong correlation between the number of organ dysfunction markers and
the risk of mortality, validating its use in low-resource, high-mortality settings. The WHO
near-miss approach proves to be applicable in this setting with only 5.0% (4 out of 79) of
maternal death cases without documentation of organ dysfunction markers.
Strengths and limitations
To our knowledge, this is the first study to analyse the correlation between markers of organ
dysfunction and mortality risk since the seminal study in Brazil. As such, it is the first to
Table 3. Frequency of organ dysfunction in cases with a severe maternal outcome.
Type of organ dysfunction SMO (N = 335)
% (N)
MNM (N = 256)
% (N)
MD (N = 79)
% (N)
MD vs. MNM
RR (95% CI)
Cardiovascular dysfunction 46 (153) 35 (89) 81 (64) 5.08 (3.02–8.53)
Respiratory dysfunction 35 (116) 23 (58) 73 (58) 5.21 (3.34–8.14)
Coagulation or haematological dysfunction 52 (173) 59 (152) 27 (21) 0.34 (0.22–0.53)
Uterine dysfunction or hysterectomy 29 (96) 32 (81) 19 (15) 0.58 (0.35–0.97)
Neurological dysfunction 11 (36) 4 (11) 32 (25) 3.85 (2.78–5.32)
Hepatic dysfunction 3 (10) 3 (1) 9 (7) 3.97 (2.85–5.54)
Renal dysfunction 17 (56) 13 (32) 30 (24) 2.17 (1.48–3.19)
Any organ dysfunction 99 (331) 100 (256) 95 (75)
https://doi.org/10.1371/journal.pone.0217135.t003
Table 4. Accuracy of the WHO set of severity markers in the prediction of maternal deaths.
All women, N = 26,842
Maternal deaths
+ ─
Any WHO criterion + 75 2561
─ 4 26,507
Sensitivity (95% CI) (%) 94.9 (87.5–98.6)
Specificity (95% CI) (%) 99.0 (98.9–99.2)
Positive likelihood ratio (95% CI) 99.3 (87.0–113.3)
Negative likelihood ratio (95% CI) 0.05 (0.02–0.13)
1) The maternal near-misses in these calculations are considered the false positives
https://doi.org/10.1371/journal.pone.0217135.t004
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validate WHO’s near-miss approach in a high mortality setting. Strengths of our study are its
prospective character and the large cohort size enabling the results to even out random varia-
tions in the incidence of rare outcomes. The main limitations are the relatively poor quality of
documentation in clinical files and the unavailability of a number of WHO near-miss criteria.
This has surely caused underestimation of markers of organ dysfunction and might partly
explain the difference in the slope of the correlation between number of organ dysfunctions
and mortality risk between Zanzibar and Brazil.
Interpretation
This study demonstrates the validity of WHO’s near-miss approach in a high maternal mortal-
ity context. First, the criteria proved to have a high accuracy in identifying patients with life-
threatening disorders at serious risk of dying. Second, the number of signs of organ dysfunc-
tion is strongly positively correlated to the mortality risk, comparable to that observed in the
seminal study in Brazil [6]. Third, the number of women who died without documented signs
of organ dysfunction is low, even in this setting where poor documentation is a major issue.
Those cases were all four of women who arrived to MMH in near-death condition and there
was no to little diagnostics and treatment, nor documentation, performed.
As expected in a high maternal mortality, low-resource setting, the mortality risk increases
much more quickly with the number of organ dysfunction markers, compared to a moderate
Fig 1. Association between number of severity markers and mortality risk in Zanzibar’s referral hospital (filled circles) and in multiple centres in Brazil
aggregated (open circles) [6]. The circles’ diameter is proportional to the number of cases.
https://doi.org/10.1371/journal.pone.0217135.g001
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or low maternal mortality setting. A patient with one sign of organ dysfunction has a risk of
mortality of 5%, one with two signs a risk of 10%. A comparable level of mortality risk is only
reached in patients with three markers of organ dysfunction in Brazil. At least part of this dis-
tinction reflects the difference in quality of care between the Brazilian centres and MMH. This
suggests that women in high-mortality settings do not die (solely) because their condition is
more severe than elsewhere but because of sub-optimal quality of care.
In assessing cases of patients in life-threatening condition, underestimation likely has
played a role as organ dysfunction markers are not measured comprehensively due to limited
diagnostic and therapeutic possibilities in MMH. This is mostly reflected in the incidence of
laboratory-based criteria, which is lower in high-mortality, low-resource settings, including
this study’s, compared to moderate mortality settings, as shown in a large multi-country study
[7]. Incomplete patient file documentation by health workers as well as a poor file-keeping
infrastructure in MMH also contribute.
As expected, there is a difference in types of organ dysfunction between patients surviving
and those dying in this cohort. The latter are more likely to have suffered from cardiovascular
and/or respiratory collapse while the former are more likely to have experienced haematogi-
cal/coagulation dysfunction and uterine dysfunction. These findings are comparable to those
found by others [1,7,8]. This distinction is insightful, showing that, despite identifying patients
in life-threatening condition through the same set of criteria, the ones that survive are often on
different pathways than the ones that die, and vice versa. This, firstly, encourages more
research into the various characteristics within the group of severely ill patients, including
sociodemographic, pregnancy-related, patient’s behaviour-related and received care-related
characteristics. Secondly, it can inform policy-making for resource allocation, promoting the
necessary diagnostic and management skills and tools, e.g. organ function laboratory test, CPR
training and blood product availability.
Including severe morbidity next to mortality improves the assessment of a setting’s quality
of maternal health care, going beyond the long-used indicator MMR. Doing this with a
selected approach, that allows for local adjustment, enables comparability between settings
and over time, which is relevant to making, implementing and reviewing policies for quality
improvement. The mortality index allows to correct for the severity of the population studied
because, irrespective of the background population case-mix, it puts the maternal death rate in
perspective to the only group at significant risk of dying. As such, it provides a more accurate
measure of the impact of clinical care than when using the maternal mortality rate alone, pro-
vided that near-miss cases are selected following well-defined, widely applicable, though
locally-adjusted criteria.
The robustness of any conclusion on the quality of care is dependent on the quality of the
data collected and challenges in this should be acknowledged and addressed in maternal mor-
bidity registration. We recommend adhering to WHO’s near-miss criteria, adjusted to the spe-
cific setting as needed, because it enables meaningful comparison between similar reference
populations. We show in our study that it is applicable and valid also in low-resource, high-
mortality settings.
Conclusion
WHO’s near-miss approach adequately identifies women at high risk of maternal mortality in
Zanzibar’s referral hospital. There is a strong correlation between the number of markers of
organ dysfunction and mortality risk while only very few mortality cases do not fulfil any
WHO criteria. The mortality index is an appropriate measure of quality of maternal health
care complementing mortality rates.
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